Yiming Luo

583 total citations · 1 hit paper
35 papers, 355 citations indexed

About

Yiming Luo is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yiming Luo has authored 35 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Immunology. Recurrent topics in Yiming Luo's work include Acute Myeloid Leukemia Research (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Seed and Plant Biochemistry (4 papers). Yiming Luo is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Histone Deacetylase Inhibitors Research (4 papers) and Seed and Plant Biochemistry (4 papers). Yiming Luo collaborates with scholars based in China, South Korea and United States. Yiming Luo's co-authors include Limin Xia, Zhijuan Lin, Bing Xu, Zhifeng Li, Zhen Lei, Tiantian Wang, Xiaoping Chen, Wenjie Huang, Bi‐Feng Liu and Yiwei Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Yiming Luo

32 papers receiving 349 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion

2024 72 citations Junli Lu, Yiming Luo et al. Experimental Hematology and Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yiming Luo China	11	155	93	88	58	40	35	355
Xingkui Xue China	10	176 1.1×	89 1.0×	76 0.9×	20 0.3×	28 0.7×	19	335
Cong Fu China	12	207 1.3×	46 0.5×	47 0.5×	60 1.0×	20 0.5×	16	336
Immacolata Vocca Italy	9	176 1.1×	119 1.3×	27 0.3×	171 2.9×	38 0.9×	10	462
Xue Jun Zhang China	11	180 1.2×	90 1.0×	101 1.1×	42 0.7×	30 0.8×	22	376
Maryam Beigom Mobasheri Iran	12	278 1.8×	47 0.5×	101 1.1×	87 1.5×	15 0.4×	19	423
Eliene O. Kozlowski Brazil	11	178 1.1×	54 0.6×	148 1.7×	41 0.7×	24 0.6×	14	449
Aleksander Myszka Poland	9	200 1.3×	70 0.8×	27 0.3×	31 0.5×	23 0.6×	19	395
Sonja Bauer Germany	8	96 0.6×	48 0.5×	39 0.4×	31 0.5×	62 1.6×	8	318
Yang Han China	16	417 2.7×	94 1.0×	75 0.9×	168 2.9×	24 0.6×	43	612

Countries citing papers authored by Yiming Luo

Since Specialization

Citations

This map shows the geographic impact of Yiming Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Luo more than expected).

Fields of papers citing papers by Yiming Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Luo. The network helps show where Yiming Luo may publish in the future.

Co-authorship network of co-authors of Yiming Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Yiming Luo. A scholar is included among the top collaborators of Yiming Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiming Luo. Yiming Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhuang, Xinguo, Shuman Jia, Hui Zhou, et al.. (2025). Chidamide and anlotinib synergistically inhibit high grade B-cell lymphomas via PI3K/AKT signaling pathway. Scientific Reports. 15(1). 29526–29526.

Fan, Fangfang, Zheng Dong, Yiming Luo, et al.. (2025). Comparison between vascular age based on brachial-ankle pulse wave velocity or carotid-femoral pulse wave velocity. Hypertension Research. 48(9). 2315–2325. 1 indexed citations

Fu, Yuting, Biao Duan, Peng Zheng, et al.. (2025). Genetically modified bacterial vesicles with interferon-γ and tumor antigen remodel anti-tumor cellular immunity by modulating dendritic cells. Biomaterials. 324. 123524–123524.

Zhang, Xiuxiu, Ruiwen Wu, Yiming Luo, et al.. (2025). Discovery of novel 8-hydroxyquinoline derivatives as NLRP3 inflammasome inhibitors with therapeutic potential for inflammatory bowel disease. European Journal of Medicinal Chemistry. 298. 118023–118023. 1 indexed citations

Wu, Ruiwen, Xiuxiu Zhang, Yiming Luo, et al.. (2025). Discovery, synthesis, and biological mechanism evaluation of novel quinoline derivatives as potent NLRP3 inhibitors. European Journal of Medicinal Chemistry. 289. 117466–117466. 1 indexed citations

Luo, Yiming, Junli Lu, Zhen Lei, et al.. (2024). GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway. Cell Death and Disease. 15(10). 715–715. 4 indexed citations

Lu, Junli, Yiming Luo, Tiantian Wang, et al.. (2024). Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Experimental Hematology and Oncology. 13(1). 39–39. 72 indexed citations breakdown →

Zhou, Hui, Wenjuan Li, Jie Zhou, et al.. (2023). Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia. Cell Death and Disease. 14(8). 573–573. 9 indexed citations

Xu, Jingjing, Quanyi Lu, Yiming Luo, et al.. (2023). When is the best time and grade to start ruxolitinib in corticosteroid‐refractory acute graft‐versus‐host‐disease: A multi‐center research. Clinical Transplantation. 38(1). e15195–e15195. 1 indexed citations

10.

Zhou, Yinghua, Yiming Luo, Xiuxiu Zhang, et al.. (2023). Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease. RSC Medicinal Chemistry. 15(1). 193–206. 4 indexed citations

11.

Wu, Qi, Xue Bai, Yiming Luo, et al.. (2023). Identification of the global diurnal rhythmic transcripts, transcription factors and time-of-day specific cis elements in Chenopodium quinoa. BMC Plant Biology. 23(1). 96–96. 3 indexed citations

12.

Wang, Tiantian, et al.. (2022). RHO GTPase family in hepatocellular carcinoma. Experimental Hematology and Oncology. 11(1). 91–91. 36 indexed citations

13.

Bai, Xue, et al.. (2021). Characterization of the first complete chloroplast genome of Amaranthus hybridus (Caryophyllales: Amaranthaceae) with phylogenetic implications. SHILAP Revista de lepidopterología. 6(11). 3306–3308. 2 indexed citations

14.

Wu, Qi, Yiming Luo, Xiaoyong Wu, et al.. (2021). Identification of the specific long-noncoding RNAs involved in night-break mediated flowering retardation in Chenopodium quinoa. BMC Genomics. 22(1). 284–284. 9 indexed citations

15.

Wu, Qi, Xue Bai, Xiaoyong Wu, et al.. (2020). Transcriptome profiling identifies transcription factors and key homologs involved in seed dormancy and germination regulation of Chenopodium quinoa. Plant Physiology and Biochemistry. 151. 443–456. 24 indexed citations

16.

Deng, Manman, Yuanfei Shi, Kai Chen, et al.. (2018). CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo. Experimental Cell Research. 369(2). 356–362. 7 indexed citations

17.

Lin, Zhijuan, Xing Chen, Zhifeng Li, et al.. (2018). The role of bortezomib in newly diagnosed diffuse large B cell lymphoma: a meta-analysis. Annals of Hematology. 97(11). 2137–2144. 12 indexed citations

18.

Luo, Yiming, et al.. (2017). Tibiotalocalcaneal (TTC) arthrodesis with reverse PHILOS plate and medial cannulated screws with lateral approach. BMC Musculoskeletal Disorders. 18(1). 317–317. 12 indexed citations

19.

Yao, Qian, Juan Du, Jie Lin, et al.. (2015). Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma. Journal of Clinical Pathology. 69(2). 122–127. 8 indexed citations

20.

Luo, Yiming, et al.. (1999). Rapid Extraction of Clenbuterol from Human and Calf Urine Using Empore™ C8 Extraction Disks. Journal of Analytical Toxicology. 23(7). 632–365. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact